Stock listing
Copenhagen:EMBLA Embla Medical hf Aktie
Home listing (Copenhagen) of Embla Medical hf
Follow Embla Medical hf into a list and get an email when it puts out news.
Share price · OMXCOP:EMBLA
27.40 DKK +0.05 (+0.2%)
Close on Nov 20, 2026
- Day range
- 26.95 – 27.75 DKKNov 20, 2026
- Volume
- 239,359 sharesNov 20, 2026
- Market cap
- 11.65B DKKAt the close on Nov 20, 2026 · price × 425.2M shares outstanding
- 52-week range
- 25.00 – 37.90 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 2.83M DKKMedian day 55,597 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:EMBLA · Home | 27.40 DKK | +0.05 (+0.2%) | 239,359 | 27.05 | 27.75 | 26.95 | 27.35 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:EMBLA · DKK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 27.40 | +0.05 | +0.2% | 27.05 | 27.75 | 26.95 | 239,359 | |
| 27.35 | -0.05 | -0.2% | 27.35 | 27.80 | 27.30 | 117,522 | |
| 27.40 | -0.40 | -1.4% | 27.85 | 27.90 | 27.20 | 117,264 | |
| 27.80 | -0.30 | -1.1% | 28.10 | 28.30 | 27.70 | 124,411 | |
| 28.10 | +0.20 | +0.7% | 27.90 | 28.45 | 27.55 | 158,108 | |
| 27.90 | -0.20 | -0.7% | 28.50 | 28.80 | 27.80 | 107,288 | |
| 28.10 | -0.60 | -2.1% | 28.85 | 28.85 | 27.95 | 447,895 | |
| 28.70 | +0.75 | +2.7% | 28.20 | 28.90 | 28.20 | 87,643 | |
| 27.95 | -0.15 | -0.5% | 27.65 | 28.15 | 27.65 | 1,251,279 | |
| 28.10 | +0.85 | +3.1% | 27.20 | 28.40 | 27.20 | 839,725 | |
| 27.25 | +0.30 | +1.1% | 26.90 | 27.35 | 26.80 | 67,216 | |
| 26.95 | -0.45 | -1.6% | 27.50 | 27.55 | 26.95 | 58,759 | |
| 27.40 | +0.40 | +1.5% | 27.00 | 27.55 | 27.00 | 55,597 | |
| 27.00 | -0.05 | -0.2% | 27.10 | 27.70 | 27.00 | 29,181 | |
| 27.05 | -0.15 | -0.6% | 27.40 | 27.45 | 26.85 | 86,591 | |
| 27.20 | +0.45 | +1.7% | 26.75 | 27.40 | 26.60 | 53,382 | |
| 26.75 | -0.40 | -1.5% | 27.15 | 27.50 | 26.75 | 51,043 | |
| 27.15 | +0.60 | +2.3% | 26.70 | 27.40 | 26.70 | 64,079 | |
| 26.55 | +0.35 | +1.3% | 26.30 | 26.65 | 26.15 | 65,799 | |
| 26.20 | +0.15 | +0.6% | 26.05 | 26.20 | 25.55 | 93,782 | |
| 26.05 | 0.00 | 0.0% | 26.05 | 26.75 | 26.00 | 109,778 | |
| 26.05 | -1.45 | -5.3% | 26.40 | 26.85 | 25.70 | 175,371 | |
| 27.50 | -0.15 | -0.5% | 27.65 | 28.25 | 27.50 | 36,830 | |
| 27.65 | +0.25 | +0.9% | 27.35 | 28.40 | 27.35 | 30,113 | |
| 27.40 | -0.15 | -0.5% | 27.55 | 27.70 | 27.30 | 34,130 | |
| 27.55 | +0.35 | +1.3% | 27.25 | 27.60 | 27.00 | 34,169 | |
| 27.20 | +0.15 | +0.6% | 27.10 | 27.55 | 27.05 | 34,384 | |
| 27.05 | -0.60 | -2.2% | 27.70 | 27.75 | 27.00 | 75,564 | |
| 27.65 | -0.10 | -0.4% | 27.80 | 28.00 | 27.25 | 74,403 | |
| 27.75 | -0.10 | -0.4% | 27.85 | 27.85 | 27.50 | 14,144 | |
| 27.85 | +0.20 | +0.7% | 27.60 | 28.00 | 27.55 | 34,514 | |
| 27.65 | +1.00 | +3.8% | 26.50 | 27.85 | 26.50 | 51,515 | |
| 26.65 | +0.05 | +0.2% | 26.65 | 26.90 | 26.45 | 23,533 | |
| 26.60 | +0.25 | +0.9% | 27.40 | 27.40 | 26.45 | 41,718 | |
| 26.35 | -0.80 | -2.9% | 27.15 | 27.30 | 26.35 | 46,295 | |
| 27.15 | -0.20 | -0.7% | 27.35 | 27.50 | 27.00 | 18,856 | |
| 27.35 | -0.10 | -0.4% | 27.45 | 27.50 | 27.10 | 22,721 | |
| 27.45 | +0.10 | +0.4% | 27.15 | 27.65 | 27.15 | 19,301 | |
| 27.35 | 0.00 | 0.0% | 27.40 | 27.60 | 27.25 | 15,516 | |
| 27.35 | 0.00 | 0.0% | 27.45 | 27.50 | 27.10 | 26,173 | |
| 27.35 | +0.10 | +0.4% | 27.15 | 27.65 | 27.15 | 56,672 | |
| 27.25 | 0.00 | 0.0% | 27.60 | 27.75 | 27.05 | 57,386 | |
| 27.25 | 0.00 | 0.0% | 28.00 | 28.00 | 27.10 | 35,525 | |
| 27.25 | +0.05 | +0.2% | 27.25 | 27.45 | 27.05 | 25,741 | |
| 27.20 | +0.15 | +0.6% | 27.00 | 27.55 | 27.00 | 42,194 | |
| 27.05 | -0.15 | -0.6% | 27.20 | 27.35 | 26.50 | 76,964 | |
| 27.20 | 0.00 | 0.0% | 27.00 | 27.50 | 27.00 | 57,255 | |
| 27.20 | +0.05 | +0.2% | 28.00 | 29.20 | 26.95 | 77,835 | |
| 27.15 | -0.55 | -2.0% | 27.70 | 27.90 | 26.90 | 79,417 | |
| 27.70 | -0.15 | -0.5% | 28.25 | 28.30 | 27.40 | 90,431 | |
| 27.85 | -0.60 | -2.1% | 28.65 | 28.65 | 27.80 | 43,827 | |
| 28.45 | +0.05 | +0.2% | 28.35 | 28.70 | 28.05 | 35,244 | |
| 28.40 | -0.35 | -1.2% | 28.00 | 28.70 | 27.50 | 52,672 | |
| 28.75 | -0.25 | -0.9% | 28.80 | 29.25 | 28.35 | 52,100 | |
| 29.00 | -0.05 | -0.2% | 29.75 | 29.75 | 28.80 | 84,121 | |
| 29.05 | +0.05 | +0.2% | 29.05 | 29.20 | 28.85 | 21,679 | |
| 29.00 | -0.20 | -0.7% | 29.15 | 29.35 | 29.00 | 54,133 | |
| 29.20 | -0.20 | -0.7% | 29.40 | 29.60 | 29.15 | 141,680 | |
| 29.40 | -0.10 | -0.3% | 29.50 | 29.60 | 29.10 | 26,208 | |
| 29.50 | +0.35 | +1.2% | 28.90 | 29.60 | 28.70 | 120,385 | |
| 29.15 | -1.00 | -3.3% | 30.10 | 30.25 | 28.50 | 185,127 | |
| 30.15 | -0.10 | -0.3% | 30.35 | 30.45 | 30.15 | 15,979 | |
| 30.25 | +0.25 | +0.8% | 30.00 | 30.40 | 29.95 | 49,749 | |
| 30.00 | +0.25 | +0.8% | 29.55 | 30.10 | 29.45 | 59,649 | |
| 29.75 | 0.00 | 0.0% | 29.65 | 29.80 | 29.55 | 26,867 |
- Ticker
- Copenhagen:EMBLA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Copenhagen
- Currency
- DKK
What changed lately
Latest news release · Jul 17, 2026
Embla Medical hf: Initiating New Share Buyback Program
Latest earnings call · Jul 21, 2026
Embla Medical HF (Copenhagen:EMBLA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Oct 20, 2026
Embla Medical — Q3 2026 Earnings Presentation
Earnings · 78 slides
Latest news
Embla Medical hf: Initiating New Share Buyback Program
Jul 17, 2026
Closed 26.50 (0.0%) on Jul 17, 2026
Embla Medical hf: Share Buyback Program Completed
Jul 17, 2026
Closed 26.50 (0.0%) on Jul 17, 2026
Embla Medical hf: Transactions in relation to Share Buyback Program
May 26, 2026
Closed 26.80 (-0.4%) on May 27, 2026
Embla Medical hf: Interim Report Q1 2026
Apr 28, 2026
Closed 26.70 (-3.4%) on Apr 28, 2026
Embla Medical hf: Conference call details for Q1 2026
Apr 20, 2026
Closed 28.80 (-0.7%) on Apr 20, 2026
Embla Medical hf: Registration of capital reduction of 2,441,257 shares completed
Mar 13, 2026
Closed 28.00 (+1.4%) on Mar 16, 2026
Embla Medical hf: Results of the Annual General Meeting 2026
Mar 10, 2026
Closed 29.60 (+0.7%) on Mar 10, 2026
Embla Medical hf: Candidates to the Board of Directors
Mar 5, 2026
Closed 29.60 (-1.3%) on Mar 5, 2026
Embla Medical hf: Final Agenda and Proposals for the 2026 Annual General Meeting
Feb 24, 2026
Closed 29.80 (-1.3%) on Feb 24, 2026
Embla Medical hf: Notice to 2026 Annual General Meeting
Feb 17, 2026
Closed 30.30 (0.0%) on Feb 17, 2026
Embla Medical hf on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 11 in the last 12 months · 17 in all · newest Jul 17, 2026 · oldest 2025
- Calls
- 9 calls with a replay · 9 with a transcript · latest Jul 21, 2026
- Decks
- 10 decks · latest Oct 20, 2026
Where Embla Medical hf is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:EMBLA · Home listing · This page | Copenhagen | Denmark | DKK |
| OTC:OSSUY | OTC | United States | USD |
| LSE:0FIW | LSE | United Kingdom | DKK |
| OTC:OSSFF | OTC | United States | USD |
| Frankfurt:5IQ | Frankfurt | Germany | EUR |
| Aquis:EMBLAC | Aquis | United Kingdom | DKK |
| Aquis:EMBLAC | Aquis | United Kingdom | DKK |
| Turquoise:EMBLAC | Turquoise | United Kingdom | DKK |
Valuation
P/E 18.2× against a median of 20.6×: 5th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 14.41B DKK
- P/E
- 18.2×
- EV/sales
- 2.1×
- EV/EBITDA
- 10.4×
- Price/book
- 1.8×
- Gross margin
- 59.1%
- Operating margin
- 14.0%
- Net margin
- 9.5%
- Debt to equity
- 0.5×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Embla Medical hf · OMXCOP:EMBLA | US$1.71B | US$2.12B | 18.2× | 2.1× | 10.4× | 1.8× | 9.5% | 0.5× | n/a |
| Shandong Weigao Group Medical Polymer Co. Ltd. Class H · HKEX:1066 | US$1.80B | US$1.20B | 7.4× | 0.6× | 3.0× | 0.5× | 12.0% | 0.2× | n/a |
| Poly Medicure Limited · NSE:POLYMED | US$1.79B | US$1.70B | 52.1× | 7.4× | 32.6× | 5.1× | 14.9% | 0.0× | n/a |
| Top Glove Corporation Bhd. · MYX:TOPGLOV | US$1.79B | US$1.75B | 23.8× | 1.7× | 9.9× | 1.5× | 7.3% | 0.2× | n/a |
| Medartis Holding AG · SIX:MED | US$1.69B | US$1.91B | 170× | 6.0× | 58.5× | 5.0× | 3.1% | 0.7× | n/a |
| LeMaitre Vascular, Inc. · NASDAQ:LMAT | US$1.68B | US$1.48B | 26.6× | 5.5× | 17.4× | 3.9× | 23.5% | 0.4× | 0.58 |
| Dentsply Sirona Inc. · NASDAQ:XRAY | US$1.65B | US$3.44B | n/a | 1.0× | 12.1× | 1.2× | −3.4% | 1.5× | 1.03 |
| Angelalign Technology Inc. · HKEX:6699 | US$1.60B | −US$354.3M | 5.7× | −0.1× | −0.7× | 0.6× | 9.3% | 0.2× | n/a |
| Inspire Medical Systems, Inc. · NYSE:INSP | US$1.60B | US$1.27B | 15.8× | 1.4× | 36.9× | 1.9× | 11.4% | 0.0× | 1.00 |
| Shanghai MicroPort Endovascular MedTech Co., Ltd Class A · SSE:688016 | US$1.52B | US$1.21B | 17.4× | 5.5× | n/a | 2.4× | 40.1% | 0.0× | n/a |
| Vitrolife AB · OMXSTO:VITR | US$1.50B | US$1.58B | n/a | 4.7× | n/a | 1.9× | −144.2% | 0.2× | n/a |
| Median of the others | US$1.67B | US$1.53B | 20.6× | 3.2× | 14.7× | 1.9× | 10.4% | 0.2× | 1.00 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 31.90 DKK · Analysts' mean
- EPS, year to Dec 2026
- 1.54 · 5 analysts
- Revenue, year to Dec 2026
- 1.01B · 5 analysts
Team and board
| Officer | Role |
|---|---|
| Sveinn Sölvason | President and CEO |
| Klaus Sindahl | Head of Investor Relations |
Events
- Next results
- Feb 2, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Embla Medical HF (Copenhagen:EMBLA) Q2 2026 Earnings Call | Tue, Jul 21, 2026 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q1 2026 Earnings Call | Tue, Apr 28, 2026 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q4 2025 Earnings Call | Tue, Feb 03, 2026 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q3 2025 Earnings Call | Tue, Oct 21, 2025 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q2 2025 Earnings Call | Tue, Jul 22, 2025 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q1 2025 Earnings Call | Tue, Apr 29, 2025 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q4 2024 Earnings Call | Wed, Feb 05, 2025 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q3 2024 Earnings Call | Tue, Oct 22, 2024 · 3:00 AM ET | Replay |
| Embla Medical HF (Copenhagen:EMBLA) Q2 2024 Earnings Call | Tue, Jul 23, 2024 · 3:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 20, 2026 · Before open | −5.3% |
| Q2 2026 | Jul 21, 2026 · Before open | +3.4% |
| Q1 2026 | Apr 28, 2026 · After close | −0.6% |
| Q4 2025 | Feb 3, 2026 · Before open | +0.3% |
| Q3 2025 | Oct 21, 2025 · Before open | +4.4% |
| Q2 2025 | Jul 22, 2025 · Before open | +0.3% |
| Q1 2025 | Apr 29, 2025 · Before open | +4.2% |
| Q4 2024 | Feb 5, 2025 | −3.5% |
| Q3 2024 | Oct 22, 2024 · Before open | 0.0% |
| Q2 2024 | Jul 23, 2024 · Before open | +4.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Apr 23, 2024 · Before open | +2.0% |
| Q4 2023 | Jan 30, 2024 · Before open | +4.4% |
| Q3 2023 | Oct 24, 2023 · Before open | +3.0% |
| Q2 2023 | Jul 25, 2023 · Before open | +1.7% |
| Q1 2023 | Apr 25, 2023 · Before open | −1.8% |
| Q4 2022 | Jan 31, 2023 · Before open | −3.4% |
| Q3 2022 | Oct 25, 2022 · Before open | −1.8% |
| Q2 2022 | Jul 21, 2022 · Before open | +5.0% |
| Q1 2022 | Apr 26, 2022 · Before open | −5.5% |
| Q4 2021 | Feb 1, 2022 · Before open | +4.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Embla Medical — Q3 2026 Earnings Presentation | Earnings | 78 slides | Oct 20, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 79 slides | Jul 21, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 68 slides | Apr 28, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 70 slides | Feb 3, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 12 slides | Oct 21, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 13 slides | Jul 22, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 12 slides | Apr 29, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 12 slides | Feb 5, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 14 slides | Oct 22, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 13 slides | Jul 23, 2024 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 963.6M | 854.9M | 799.1M | 718.6M | 718.7M | 629.5M | 686.3M | 612.9M | 568.6M | 520.7M |
| Cost of revenue | 403.0M | 320.2M | 300.1M | 278.9M | 263.3M | 238.3M | 247.6M | 226.1M | 213.8M | 192.3M |
| Gross profit | 560.6M | 534.7M | 485.6M | 439.7M | 455.4M | 391.2M | 438.6M | 386.8M | 354.8M | 328.4M |
| Research and development | 41.0M | 40.8M | 38.1M | 34.0M | 31.7M | 31.0M | 31.3M | 31.4M | 28.9M | 23.2M |
| Selling, general and administrative | 73.8M | 70.0M | 66.9M | 72.5M | 74.1M | 77.7M | 76.0M | 70.3M | 63.7M | 58.1M |
| Operating income | 129.4M | 112.8M | 89.4M | 67.1M | 95.6M | 53.3M | 99.2M | 90.5M | 80.5M | 72.2M |
| Depreciation and amortization | 62.9M | 56.0M | 49.9M | 49.4M | 51.5M | 64.7M | 43.6M | 28.4M | 22.6M | 21.7M |
| EBITDA | 192.3M | 168.7M | 139.3M | 116.5M | 147.2M | 118.0M | 142.8M | 118.9M | 103.0M | 93.9M |
| Interest expense | 21.9M | 23.2M | 18.0M | 11.2M | 9.80M | 9.61M | 8.33M | 3.76M | 3.20M | 2.73M |
| Income before tax | 112.0M | 90.6M | 76.0M | 56.2M | 86.6M | 12.7M | 90.3M | 96.9M | 68.7M | 68.4M |
| Income tax | 25.2M | 21.6M | 17.2M | 13.0M | 21.0M | 4.80M | 21.4M | 17.1M | 11.1M | 17.4M |
| Net income | 86.5M | 68.3M | 58.4M | 42.5M | 64.0M | 6.21M | 66.0M | 79.8M | 57.6M | 51.0M |
| Earnings per share, basic | 0.20 | 0.16 | 0.14 | 0.10 | 0.15 | 0.01 | 0.16 | 0.19 | 0.13 | 0.12 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 102.3M | 86.2M | 72.7M | 76.6M | 85.2M | 102.4M | 58.6M | 55.7M | 37.3M | 35.1M |
| Receivables | 153.2M | 121.9M | 151.0M | 131.2M | 120.7M | 124.8M | 131.0M | 118.4M | 108.4M | 96.2M |
| Inventory | 165.3M | 143.1M | 136.2M | 132.1M | 104.0M | 93.2M | 112.0M | 95.9M | 82.3M | 75.3M |
| Current assets | 457.0M | 397.0M | 376.0M | 348.8M | 318.2M | 326.5M | 307.4M | 274.0M | 232.2M | 210.7M |
| Goodwill | 833.7M | 776.3M | 690.9M | 680.4M | 644.2M | 612.2M | 521.0M | 500.8M | 414.7M | 394.1M |
| Total assets | 1.74B | 1.54B | 1.39B | 1.33B | 1.25B | 1.21B | 1.09B | 913.6M | 793.0M | 746.4M |
| Accounts payable | 32.8M | 27.3M | 30.7M | 28.7M | 26.7M | 20.0M | 26.7M | 28.1M | 23.4M | 17.8M |
| Current liabilities | 308.9M | 209.3M | 196.2M | 237.0M | 186.5M | 147.3M | 141.1M | 117.6M | 126.8M | 114.0M |
| Long-term debt | 292.2M | 328.8M | 311.8M | 277.7M | 262.2M | 340.0M | ||||
| Total debt | 541.6M | 499.8M | 467.7M | 480.9M | 448.2M | 483.4M | 360.2M | 235.5M | 158.7M | 154.5M |
| Total liabilities | 848.7M | 758.3M | 680.7M | 689.9M | 620.3M | 637.1M | 521.7M | 376.0M | 292.6M | 279.2M |
| Shareholders' equity | 888.6M | 777.2M | 701.9M | 635.7M | 621.6M | 572.5M | 564.4M | 534.5M | 499.9M | 466.4M |
| Shares outstanding | 427.0M | 426.7M | 420.3M | 417.8M | 422.8M | 422.7M | 424.6M | 426.5M | 432.4M | 440.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 141.8M | 116.1M | 94.3M | 60.8M | 100.5M | 92.2M | 95.3M | 69.4M | 73.9M | 66.3M |
| Capital spending | -22.9M | -39.2M | -42.3M | -25.9M | -26.7M | -24.0M | -31.9M | -30.9M | -19.2M | -24.6M |
| Free cash flow | 118.9M | 76.8M | 52.0M | 34.8M | 73.8M | 68.2M | 63.4M | 38.6M | 54.7M | 41.7M |
| Cash from investing | -57.4M | -57.1M | -66.3M | -59.4M | -106.4M | -62.4M | -92.1M | -19.4M | -86.9M | |
| Cash from financing | -72.3M | -41.0M | 3.79M | -51.1M | 51.9M | -29.3M | 44.4M | -56.4M | 31.9M | |
| Dividends paid | -9.28M | -9.06M | -9.18M | -7.34M | -7.81M | |||||
| Share buybacks | -10.1M | 0 | 0 | -9.94M | 0 | -3.94M | -20.6M | -19.3M | -36.1M | -27.8M |
| Change in cash | 4.93M | 17.1M | -3.98M | -8.57M | -17.2M | 43.8M | 2.90M | 18.4M | 2.18M | 9.38M |
Cap table
Built by 6ix from Embla Medical hf’s releases
- Common shares
- 425,214,514
- Fully diluted
- 425,214,514
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 425,214,514 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 425,214,514 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Klaus Sindahl | Head of Investor Relations · Since at least Jul 17, 2026 |
| Sveinn Sölvason | President and CEO · Since at least Apr 28, 2026 |
Log in to ask 6ix AI your own questions about Embla Medical hf.